advertisement

Topcon

Shi W 11

Showing records 1 to 11 | Display all abstracts from Shi W

66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Olmos LC
Eye 2016; 30: 463-472
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Panarelli JF; Banitt MR
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Sayed MS
Eye 2016; 30: 463-472
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Gedde SJ
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Moraczewski AL
Eye 2016; 30: 463-472
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Shi W
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Gedde SJ; Rosenfeld PJ
Eye 2016; 30: 463-472
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Schiffman JC
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Shi W
Eye 2016; 30: 463-472
66268 A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C
Feuer WJ
Ophthalmology 2016; 123: 789-795
66340 Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
Feuer WJ; Lee RK
Eye 2016; 30: 463-472

Issue 17-3

Change Issue


advertisement

Nidek